From Startup to Global Impact: Ida Tin’s Role in the Femtech Revolution—Entrepreneurship in STEM Without a STEM Degree
MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought LeadershipShow Notes
The Femtech revolution with Ida Tin, founder of Clue Did Apple "forgot" to add a period tracker to the Apple Heath tracker at a time when Femtech was not a thing?
Imagine you’re pioneering a product in a completely new sector, carving out an entirely new market category. That’s the journey of Ida Tin, the co-founder of Clue, one of the largest Femtech health apps serving 10+ million active users across 190+ countries.
Ida coined the term 'Femtech,' to provide a unifying banner for the sector dedicated to women's health technology. We get to hear how it started from the ida of a home hormonal test ( a decade before home testing of anything was a thing) to taking a 100% digital approach to contraception.
🔍 What You’ll Learn: How Ida Tin co-founded Clue, one of the world’s most popular women’s health apps The origin story of the word "Femtech"—and how naming it shaped a $60B+ industry The workarounds of building a women’s health startup without a STEMM background Why data privacy, ethics, and inclusive design were non-negotiables for Clue and what happens to those who took shortcuts How to fund and grow a mission-driven product in a male-dominated VC landscape
🧠 About the Guest: Ida Tin is the co-founder of Clue, a pioneering period and fertility tracking app with over 10 million active users in 190+ countries. While she doesn't come from a traditional STEMM background, her vision and language helped define an entire sector: Femtech. Her story is one of category creation, mission-driven innovation, and challenging the norms of tech, funding, and health.
🗂️ Episode Timeline: 00:32 Meet Ida Tin: The Mother of Femtech 01:45 The Journey of Clue 03:55 Data Privacy and Ethical Considerations 07:09 Challenges and Innovations in Femtech 17:55 Building the Clue Team 33:33 The Birth of the Term 'Femtech' , definition and a new unifying banner 39:41 Inclusivity in Femtech: Bridging the Gender Gap 40:57 The Duality of Periods: Normalization vs. Medical Attention 42:28 Creating a Supportive Work Culture for Women 44:11 Challenges in Femtech: Data Gaps and Funding Issues 51:31 funding , Ethics and Success in Femtech: A Comparative Analysis 56:24 Navigating Gender Bias in Venture Capital 01:07:14 Balancing Motherhood and Entrepreneurship 01:09:23 Conclusion: Building a Unified Future
🔗 Resources & Mentions: Follow Ida Tin on LinkedIn Sign up for her upcoming Femtech book Download Clue on your app store
Want to craft a career story that opens doors? I help STEMM professionals speak with clarity, confidence, and purpose and show up as thought leaders —so the right opportunities find you. 📬 Let’s connect: angeliquegreco.com.au | LinkedIn
⭐️ Help More People Reinvent Their Careers If you enjoyed this episode, please: ✅ Leave a quick ⭐️⭐️⭐️⭐️⭐️ review on Apple Podcasts or Spotify 🙏 ♻️ Share it with a friend who's questioning their path in STEM Hosted on Acast. See acast.com/privacy for more information.
More from MULTIPLE HATS: STEM Careers | Reinvention | Entrepreneurship |Thought Leadership
You have promising science. But is there actually a commercial opportunity behind it? And if you’re considering moving from scientist to entrepreneur, how do you know whether your research has the ingredients for a biotech company?
What happens when scientists stop presenting their research to other scientists and put it in front of biotech and drug development experts instead? The questions change. Suddenly it isn’t only, “Does the science work?” It’s also: Who is the patient? What is the indication? What evidence do you need next? What could stop this programme? Who needs to partner with you? And what would a credible path to the clinic actually look like?
Should your research become a medicine? And if it has commercial potential, should you be the scientist who takes it forward? For academics considering the move from scientist to entrepreneur, that decision starts well before forming a biotech company.
A rapid-fire conversation on transferable STEM skills, working smarter, visibility and what is actually good enough to start.
How a nurse turned a recurring healthcare problem into NeedleCalm, and what ten years of building taught her about medtech entrepreneurship.